-
An Analysis of Possible Reference Countries for a US Most-Favored Nation Policy and the Associated Impact on the Global Pharmaceutical Industry
Sep 9, 2025, 16:22 PM -
An Exploration of Implementing Herd Immunity Into Static Models for Economic Evaluation of Vaccines
Sep 9, 2025, 16:22 PM -
Diabetes Trends in France (2021-2023): A Descriptive Study Based on the THIN Database
Sep 9, 2025, 16:22 PM -
Patterns of Treatment Adherence and Administration Preferences for People With Transthyretin Amyloid Cardiomyopathy: A Real-World Survey in Europe, the United States, and Japan
Sep 9, 2025, 16:22 PM -
Avacopan in the Treatment of ANCA-Associated Vasculitis: A Cost-Utility Analysis in Portugal
Sep 9, 2025, 16:22 PM -
The Burden of Cognitive Impairment Associated With Schizophrenia (CIAS) on People With Lived Experience (PWLE): A National Canadian Survey
Sep 9, 2025, 16:22 PM -
Lean Assessment Process Methodology for RMD-Health: Evaluating Clinical Need Usefulness Adoption Barriers and Early Economic Value of AI in NHS Rheumatology Referrals
Sep 9, 2025, 16:22 PM -
Assessment Of Parental Knowledge Information-Seeking and Information-Providing Regarding Newborn And Infant Screening Examinations
Sep 9, 2025, 16:22 PM -
Evaluating the Role of Societal Perspectives in the EU Joint Clinical Assessment Framework and in EU-27 Health Technology Assessment Guidelines
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Quizartinib for Adult Patients With Newly Diagnosed FLT3-ITD+ Acute Myeloid Leukemia (AML) in Spain
Sep 9, 2025, 16:22 PM -
Economic Burden of Gaucher Disease: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
The Role of Environmental Evidence in HTA: Comparative Insights Into Global Assessment Frameworks
Sep 9, 2025, 16:22 PM -
Deep Real-World Analysis of Patients With Myelofibrosis Using Natural Language Processing and Machine Learning: A Methods Description
Sep 9, 2025, 16:22 PM -
Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Ocrelizumab for Treating Relapsing Multiple Sclerosis in Austria
Sep 9, 2025, 16:22 PM -
AI Models for Predicting Clinical Trial Success: Capabilities and Risks of Pattern-Driven Approaches
Sep 9, 2025, 16:22 PM -
MCDA Tool Adoption in Egypt: Room for Sustainability and Accessibility
Sep 9, 2025, 16:22 PM -
Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA
Sep 9, 2025, 16:22 PM -
Exploring Synergistic ADC-ICI Combinations in Breast Cancer: Clinical Insights From a Scoping Review
Sep 9, 2025, 16:22 PM -
(HCRU)/Costs and Epidemiology of Patients With ADHD in Germany: A Claims Data Study (HEDDA)
Sep 9, 2025, 16:22 PM
